AC-93253 triggers the downregulation of melanoma progression markers and the inhibition of melanoma cell proliferation
- 1 July 2015
- journal article
- research article
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 236, 9-18
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Science and Higher Education in Poland
- European Regional Development Fund (POIG.01.01.02-10-107/09)
This publication has 58 references indexed in Scilit:
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E MutationNew England Journal of Medicine, 2011
- Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulationNature, 2010
- Inhibition of Mutated, Activated BRAF in Metastatic MelanomaNew England Journal of Medicine, 2010
- Defective Cell Cycle Checkpoint Functions in Melanoma Are Associated with Altered Patterns of Gene ExpressionJournal of Investigative Dermatology, 2008
- In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitroNature Protocols, 2007
- Targeting multidrug resistance in cancerNature Reviews Drug Discovery, 2006
- Activation of the DNA damage checkpoint and genomic instability in human precancerous lesionsNature, 2005
- Mutations of the BRAF gene in human cancerNature, 2002
- The Hallmarks of CancerCell, 2000
- Expression and Targeting of the Apoptosis Inhibitor, Survivin, in Human MelanomaJournal of Investigative Dermatology, 1999